Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
508.5 INR | +0.51% | +4.41% | -13.45% |
Apr. 23 | UPL Limited completed the acquisition of Cortevas Mancozeb Business from Corteva, Inc.. | CI |
Mar. 28 | UPL Limited(NSEI:UPL) dropped from Nifty 50 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in debt and has limited leeway for investment
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.45% | 4.56B | C+ | ||
-.--% | 11.13B | - | B+ | |
-7.28% | 7.21B | A | ||
+7.47% | 6.84B | B- | ||
-3.91% | 5.92B | B+ | ||
-6.14% | 5.6B | B | ||
-10.44% | 5.57B | - | C- | |
+31.35% | 5.14B | B- | ||
+17.77% | 4.4B | - | - | |
+6.27% | 3.84B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNITEDPHOS Stock
- Ratings UPL Limited